我们梳理出本月在医疗领域融资中最值得关注的企业，帮助大家及时了解全球市场动向。 LambdaVision完成700万美元天使轮融资，本轮融资由Aurelia Foundry、Seraphim Space和Seven Seven Six联合投资。LambdaVision位于美国，是一家美国人工视网膜研发商。 CustoMED获600万美元种子轮融资，Emerging Longevity Ventures、FLAG Capital Management、 Longevity Venture Partners、Varana Capital以及以色列创新局等多家投资方参与投资。CustoMED位于以 色列，是一家专注于推动外科手术个性化与精准化的医疗科技企业。 微滔生物完成超亿元人民币规模的天使轮融资。本轮融资由全球领先的创投机构启明创投领投。微滔生 物位于上海，是一家全球体内细胞治疗领域的创新企业。微滔生物基于靶向LNP递送系统开发的in vivo CAR-T疗法，专注于为血液瘤及自身免疫疾病带来革新性的治疗手段。 熙源安健完成超2亿元A轮融资。本轮融资由光华梧桐、启明创投、比邻星创投、渶策资本、顺禧基金 共同参与 ...

Core Insights - Wuxi Zijing Zhikang Technology Co., Ltd. has completed an angel round financing of nearly 100 million RMB, with participation from Xinglian Capital, Inno Angel Fund, and Shangshi Capital [1][2]. Company Overview - Zijing Zhikang was established in September 2024, with a core team from Tsinghua University's Intelligent Industry Research Institute, recognized as a leading global research team in medical intelligent algorithms [2]. - The company’s research work, Agent Hospital, establishes generative models for disease occurrence and development, providing a data flywheel for the evolution of medical intelligent agents [2]. - Agent Hospital has achieved top-level performance on the U.S. medical licensing examination dataset and has constructed medical intelligent agents across more than twenty departments, gaining significant attention from both academia and industry [2]. - The company aims to leverage cutting-edge large model intelligent technology to empower smart healthcare, offering convenient, affordable, and high-quality medical services to global users [2].